NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 160 filers reported holding NEVRO CORP in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,633 | +257.2% | 189 | +372.5% | 0.00% | – |
| Q2 2023 | $1,017 | -74.2% | 40 | -63.3% | 0.00% | – |
| Q1 2023 | $3,941 | -17.1% | 109 | -9.2% | 0.00% | – |
| Q4 2022 | $4,752 | -32.1% | 120 | -21.1% | 0.00% | – |
| Q3 2022 | $7,000 | 0.0% | 152 | 0.0% | 0.00% | – |
| Q2 2022 | $7,000 | -12.5% | 152 | +38.2% | 0.00% | – |
| Q1 2022 | $8,000 | -27.3% | 110 | -18.5% | 0.00% | – |
| Q4 2021 | $11,000 | -35.3% | 135 | -10.6% | 0.00% | – |
| Q3 2021 | $17,000 | -48.5% | 151 | -24.5% | 0.00% | – |
| Q2 2021 | $33,000 | +26.9% | 200 | +11.7% | 0.00% | – |
| Q1 2021 | $26,000 | +8.3% | 179 | +28.8% | 0.00% | – |
| Q4 2020 | $24,000 | +26.3% | 139 | +5.3% | 0.00% | – |
| Q3 2020 | $19,000 | +18.8% | 132 | 0.0% | 0.00% | – |
| Q2 2020 | $16,000 | +33.3% | 132 | +12.8% | 0.00% | – |
| Q1 2020 | $12,000 | -14.3% | 117 | -1.7% | 0.00% | – |
| Q4 2019 | $14,000 | +27.3% | 119 | 0.0% | 0.00% | – |
| Q3 2019 | $11,000 | +450.0% | 119 | +340.7% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 27 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | +100.0% | 27 | 0.0% | 0.00% | – |
| Q4 2018 | $1,000 | – | 27 | +440.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 5 | -61.5% | 0.00% | – |
| Q2 2018 | $1,000 | -99.6% | 13 | -99.5% | 0.00% | – |
| Q3 2017 | $238,000 | +25.3% | 2,627 | +3.4% | 0.00% | – |
| Q2 2017 | $190,000 | +2614.3% | 2,540 | +2753.9% | 0.00% | – |
| Q2 2016 | $7,000 | +40.0% | 89 | -4.3% | 0.00% | – |
| Q1 2016 | $5,000 | -16.7% | 93 | +3.3% | 0.00% | – |
| Q4 2015 | $6,000 | +50.0% | 90 | 0.0% | 0.00% | – |
| Q3 2015 | $4,000 | +100.0% | 90 | +95.7% | 0.00% | – |
| Q2 2015 | $2,000 | +100.0% | 46 | +76.9% | 0.00% | – |
| Q1 2015 | $1,000 | – | 26 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 403,424 | $46,950,000 | 6.74% |
| HealthCor Management, L.P. | 529,230 | $61,592,000 | 2.66% |
| Sante Capital Fund, LP | 18,963 | $2,207,000 | 2.04% |
| Jackson Square Partners, LLC | 2,452,497 | $285,421,000 | 1.81% |
| Altium Capital Management LP | 51,000 | $5,935,000 | 1.56% |
| Rock Springs Capital Management LP | 635,700 | $73,983,000 | 1.56% |
| PFM Health Sciences, LP | 392,786 | $45,712,000 | 1.34% |
| Redmile Group, LLC | 542,932 | $63,186,000 | 1.10% |
| Connacht Asset Management LP | 13,555 | $1,578,000 | 1.02% |
| Integral Health Asset Management, LLC | 30,000 | $3,491,000 | 1.00% |